Advertisement
ETON vs SIGA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETON is a Buy and SIGA is a Hold.
ETON in +19.62% Uptrend, growing for three consecutive days on November 10, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ETON advanced for three days, in 243 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ETON as a result. In 80 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ETON just turned positive on November 06, 2026. Looking at past instances where ETON's MACD turned positive, the stock continued to rise in 41 of 52 cases over the following month. The odds of a continued upward trend are 79%.
ETON moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for ETON crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ETON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
ETON broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ETON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ETON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (34.642) is normal, around the industry mean (6.379). ETON has a moderately high P/E Ratio (122.739) as compared to the industry average of (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (15.798) is also within normal values, averaging (183.387).
SIGA in +9.76% Uptrend, growing for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SIGA advanced for three days, in 229 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 57 cases where SIGA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for SIGA just turned positive on November 09, 2026. Looking at past instances where SIGA's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
SIGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SIGA as a result. In 75 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
SIGA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SIGA crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for SIGA entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.348) is normal, around the industry mean (6.379). SIGA has a moderately low P/E Ratio (-103.333) as compared to the industry average of (0.548). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.202). SIGA's Dividend Yield (0.774) is considerably higher than the industry average of (0.062). P/S Ratio (4.161) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. SIGA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
ETON | SIGA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 4 | 100 | |
SMR RATING 1..100 | 28 | 91 | |
PRICE GROWTH RATING 1..100 | 34 | 60 | |
P/E GROWTH RATING 1..100 | 13 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for ETON (90) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than ETON’s over the last 12 months.
ETON's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that ETON’s stock grew significantly faster than SIGA’s over the last 12 months.
ETON's SMR Rating (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for SIGA (91) in the Pharmaceuticals Other industry. This means that ETON’s stock grew somewhat faster than SIGA’s over the last 12 months.
ETON's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as SIGA (60) in the Pharmaceuticals Other industry. This means that ETON’s stock grew similarly to SIGA’s over the last 12 months.
ETON's P/E Growth Rating (13) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that ETON’s stock grew significantly faster than SIGA’s over the last 12 months.
| ETON | SIGA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | N/A |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 81% |
| Advances ODDS (%) | 2 days ago 83% | 3 days ago 79% |
| Declines ODDS (%) | 7 days ago 79% | 10 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 72% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ETON’s FA Score shows that 3 FA rating(s) are green while SIGA’s FA Score has 1 green FA rating(s).
- ETON’s FA Score: 3 green, 2 red.
- SIGA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ETON’s TA Score shows that 4 TA indicator(s) are bullish while SIGA’s TA Score has 4 bullish TA indicator(s).
- ETON’s TA Score: 4 bullish, 6 bearish.
- SIGA’s TA Score: 4 bullish, 5 bearish.
Price Growth
ETON (@Pharmaceuticals: Generic) experienced а +32.56% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was +0.64% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
ETON is expected to report earnings on Mar 18, 2027.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
ETON and
Correlation & Price change
A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.
| Ticker / NAME | Correlation To ETON | 1D Price Change % | ||
|---|---|---|---|---|
| ETON | 100% | +4.96% | ||
| MDGL - ETON | 34% Loosely correlated | -0.04% | ||
| SIGA - ETON | 32% Poorly correlated | -3.99% | ||
| VKTX - ETON | 31% Poorly correlated | -1.14% | ||
| ARRY - ETON | 30% Poorly correlated | -8.86% | ||
| FDMT - ETON | 29% Poorly correlated | -0.16% | ||
More | ||||
SIGA and
Correlation & Price change
A.I.dvisor indicates that over the last year, SIGA has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SIGA jumps, then EBS could also see price increases.
| Ticker / NAME | Correlation To SIGA | 1D Price Change % | ||
|---|---|---|---|---|
| SIGA | 100% | -3.99% | ||
| EBS - SIGA | 34% Loosely correlated | -0.82% | ||
| ETON - SIGA | 30% Poorly correlated | +4.96% | ||
| AMRX - SIGA | 30% Poorly correlated | +0.47% | ||
| AYTU - SIGA | 28% Poorly correlated | +1.12% | ||
| KMDA - SIGA | 27% Poorly correlated | +5.06% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ILS | 20.36 | 0.01 | +0.05% |
| Brookmont Catastrophic Bond ETF | |||
| DRUP | 66.49 | N/A | N/A |
| GraniteShares Nasdaq Select Disruptors ETF (DRUP) | |||
| BSGR | 25.01 | -0.02 | -0.08% |
| Invesco BulletShares 2027 Treasury Bond ETF (BSGR) | |||
| FPE | 17.12 | -0.22 | -1.27% |
| First Trust Preferred Securities & Income ETF (FPE) | |||
| NAIL | 35.52 | -3.86 | -9.80% |
| Direxion Daily Homebuilders & Supplies Bull 3X ETF (NAIL) | |||